Assoc. Prof. İzzet Doğan, MD

Assoc. Prof. İzzet Doğan, MD is a medical oncologist working in the Medical Oncology Department at Acibadem Bakirkoy Hospital and Acibadem Atakent Hospital in İstanbul. With more than 18 years in medicine, his practice covers a broad range of solid tumors in adults, including breast, gastrointestinal, lung and thoracic, urological, gynecological, central nervous system, skin, and head and neck cancers, as well as soft tissue and bone sarcomas and cancers of unknown primary origin.

Dr. Doğan graduated from Hacettepe University Faculty of Medicine in 2008 and began his career as a general practitioner at Korgan Çayırkent Health Center in Ordu. He completed his Internal Medicine training at Ankara University Faculty of Medicine in 2013 and then worked as an Internal Medicine specialist at Aksaray State Hospital, Kütahya Military Hospital and Antalya Training and Research Hospital. From 2018 to 2021 he trained in Medical Oncology at İstanbul University İstanbul Faculty of Medicine, completing his specialization in 2021. He subsequently practiced as a Medical Oncology specialist and later as an associate professor at Başakşehir Çam ve Sakura City Hospital before joining Acıbadem Healthcare Services in 2023. He is a member of the European Society for Medical Oncology (ESMO), the Turkish Medical Oncology Association and the Turkish Medical Association, and he has co-authored peer-reviewed publications on metastatic breast cancer, renal cell carcinoma with brain metastases, metastatic Ewing sarcoma, HER2-positive metastatic gastric cancer, ALK-mutant non-small cell lung cancer and recurrent ovarian granulosa cell tumors.

Clinical focus

A substantial part of Dr. Doğan’s clinical and research work relates to breast cancer, including early-stage disease and HER2-positive metastatic disease. He also treats gastrointestinal cancers, lung and other thoracic cancers, urological cancers, gynecological tumors, central nervous system tumors and endocrine pancreatic tumors. His practice further includes soft tissue and bone sarcomas, melanoma and other skin tumors, head and neck cancers and cancer of unknown primary, where the site of origin cannot be readily identified.

Treatment planning in his practice draws on immunotherapy and targeted therapies, informed by his interests in molecular pathology and cancer screening. The choice of systemic treatment depends on the tumor type, stage, molecular features and the patient’s general condition, and is discussed with each patient on an individual basis.

How Dr. Doğan works with international patients

Dr. Doğan consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the international patient team coordinates the collection of prior reports and imaging, arranges appointments and organizes the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging, pathology and previous treatments, a clinical examination and a discussion of the available options. Video consultation is available for international patients who wish to discuss their case with Dr. Doğan before traveling or as part of follow-up.